Alturas Analytics

Executive Summary

Alturas Analytics is a GLP-compliant bioanalytical contract research organization (CRO) headquartered in Moscow, Idaho, specializing in LC-MS/MS and GC-MS/MS services. Founded in 2000, the company supports preclinical and clinical studies, IND submissions, and New Drug Applications for pharmaceutical clients worldwide. With a focus on blending scientific passion with technical expertise, Alturas provides reliable bioanalytical solutions that are critical to drug development. As a private company, it does not disclose financials, but its long-standing presence and adherence to GLP standards position it as a trusted partner in the CRO industry. The growing trend of pharmaceutical outsourcing and increasing complexity of bioanalysis create opportunities for Alturas to expand its service offerings and client base. While limited public information constrains visibility, the company's established reputation and niche expertise suggest stable operations and potential for steady growth.

Upcoming Catalysts (preview)

• 2026Expansion of Bioanalytical Service Lines (e.g., biomarker or antibody analysis)60% success
• 2026Strategic Partnership or Collaboration with a Major Pharmaceutical Company50% success
• 2026Achievement of ISO/IEC 17025 Accreditation for Quality Management70% success